fda warns against compounded semaglutide Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about GLP-1 medications Compounded "semaglutide" is not FDA-approved

The drugs, which also include Mounjaro and Zepbound (tirzepatide), as well as Victoza and Trulicity, all belong to a class of medications known as glucagon-like peptide 1 (GLP-1) receptor agonists

Other physical reactions Headaches Dizziness for a few hours Feeling jittery or nervous briefly Mild fever These effects usually disappear within 12 days

The results showed that compared with the RBITC-GLP-1RAs@NPs group, the fluorescence intensity in the kidney was lower on the first day in the rats injected with RBITC-GLP-1RAs@NPs-WYRGRL, while the fluorescence intensity in the lower limb joints was significantly increased

doi: 10.1111/dom.15184 Retrieved from Rosenstock, J., Hsia, S., Nevarez Ruiz, L., et al